We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+0.12%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$306B
AUM Growth
+$4.93B
Cap. Flow
+$7.83B
Cap. Flow %
2.56%
Top 10 Hldgs %
17.03%
Holding
3,610
New
202
Increased
2,185
Reduced
922
Closed
109

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$269M
2
AMZN icon
Amazon
AMZN
+$242M
3
AAPL icon
Apple
AAPL
+$215M
4
AMGN icon
Amgen
AMGN
+$212M
5
CFG icon
Citizens Financial Group
CFG
+$193M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Financials 13.47%
3 Healthcare 12.09%
4 Consumer Discretionary 10.78%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WRAP icon
3426
Wrap Technologies
WRAP
$105M
$63K ﹤0.01%
10,465
MBRX icon
3427
Moleculin Biotech
MBRX
$3.2M
$61K ﹤0.01%
+54
New +$63K
WMC
3428
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$61K ﹤0.01%
2,307
-26,156
-92% -$745K
PEI
3429
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$61K ﹤0.01%
+2,075
New +$63.5K
SVRA icon
3430
Savara
SVRA
$1.14B
$60K ﹤0.01%
42,882
EGY icon
3431
Vaalco Energy
EGY
$623M
$59K ﹤0.01%
20,055
LQDA icon
3432
Liquidia Corp
LQDA
$7.75B
$58K ﹤0.01%
20,793
PANL icon
3433
Pangaea Logistics
PANL
$449M
$58K ﹤0.01%
+11,475
New +$56.3K
STSA
3434
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$58K ﹤0.01%
12,319
-22,008
-64% -$117K
HIL
3435
DELISTED
Hill International, Inc. Common Stock
HIL
$58K ﹤0.01%
+27,687
New +$64.4K
ODT
3436
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$58K ﹤0.01%
19,636
-60,800
-76% -$202K
PHLT
3437
DELISTED
Performant Healthcare Inc
PHLT
$57K ﹤0.01%
14,263
ROI
3438
DELISTED
RiskOn International, Inc. Common Stock
ROI
$57K ﹤0.01%
+356
New +$49.9K
ARC
3439
DELISTED
ARC Document Solutions, Inc.
ARC
$57K ﹤0.01%
+19,042
New +$48.7K
XERS icon
3440
Xeris Biopharma Holdings
XERS
$1.51B
$56K ﹤0.01%
22,478
CRVS icon
3441
Corvus Pharmaceuticals
CRVS
$1.22B
$55K ﹤0.01%
+11,217
New +$33.2K
DMK
3442
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$55K ﹤0.01%
804
XWEL icon
3443
XWELL
XWEL
$8.09M
$54K ﹤0.01%
1,814
LOGC
3444
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$53K ﹤0.01%
+11,498
New +$50.6K
CHRA
3445
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$52K ﹤0.01%
+1,109
New +$52.4K
BYFC icon
3446
Broadway Financial
BYFC
$104M
$51K ﹤0.01%
+1,898
New +$49.9K
DARE icon
3447
Dare Bioscience
DARE
$21.7M
$51K ﹤0.01%
+2,544
New +$50.2K
UAMY icon
3448
United States Antimony
UAMY
$969M
$51K ﹤0.01%
+55,952
New +$51.5K
ADIL
3449
Adial Pharmaceuticals
ADIL
$9.39M
$50K ﹤0.01%
+19
New +$39.8K
TLPH icon
3450
Talphera
TLPH
$76.3M
$50K ﹤0.01%
2,428

Similar funds

Charles Schwab's Q3 2021 Portfolio in Review

As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
  • Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
  • Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
  • Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
  • Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
  • Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
  • Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.

Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.